Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 106,215 | 1,225 | 0 | 0 | 0 |
| Operating Income | -106,215 | -1,225 | N/A | N/A | N/A |
| Interest Expense | 4,177 | 13 | 0 | 0 | 0 |
| Other Income | -144,739 | -50 | 0 | 0 | 0 |
| Pre-tax Income | -255,131 | -1,288 | 0 | 0 | 0 |
| Net Income Continuous | -255,131 | -1,288 | N/A | N/A | N/A |
| Net Income | $-255,131 | $-1,288 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -22.45 | -0.21 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -22.44 | -0.21 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -22.45 | -0.21 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -22.44 | -0.21 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -13.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-105,798 | $-1,225 | $N/A | $N/A | $N/A |